ArticleJournal of experimental & clinical cancer research : CR2023

CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes.

Marika Quadri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.